Detalles de la búsqueda
1.
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
Clin Infect Dis
; 68(3): 466-474, 2019 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29945169
2.
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.
Clin Infect Dis
; 69(9): 1509-1516, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30629148
3.
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.
Mol Ther
; 25(2): 547-559, 2017 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28153101
4.
Recommendations of the VAC2VAC workshop on the design of multi-centre validation studies.
Biologicals
; 52: 78-82, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29395838
5.
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.
Mol Ther
; 24(8): 1470-7, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27109630
6.
Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report.
Malar J
; 15: 476, 2016 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27639691
7.
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.
Malar J
; 15(1): 442, 2016 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27577237
8.
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Front Immunol
; 14: 1267372, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37908361
9.
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination.
Front Cell Infect Microbiol
; 12: 1058081, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36590593
10.
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
Front Immunol
; 13: 978591, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36119062
11.
Comparative decline in funding of European Commission malaria vaccine projects: what next for the European scientists working in this field?
Malar J
; 10: 255, 2011 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21880156
12.
Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses.
NPJ Vaccines
; 6(1): 55, 2021 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33854065
13.
European Malaria Vaccine Initiative: portfolio and perspectives for the future.
Hum Vaccin
; 6(1): 146-50, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20009515
14.
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.
Lancet Infect Dis
; 20(5): 585-597, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32032566
15.
Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC.
EBioMedicine
; 42: 145-156, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30885725
16.
Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow.
Vaccine
; 36(9): 1136-1145, 2018 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29395517
17.
Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development.
NPJ Vaccines
; 3: 28, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30038803
18.
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
PLoS One
; 13(12): e0208328, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30540808
19.
[Perspectives and challenges of malaria vaccine. Why we must do more]. / Espoirs et enjeux des stratégies vaccinales contre le paludisme. Pourquoi nous devons faire mieux.
Bull Acad Natl Med
; 191(7): 1249-59; discussion 1259-60, 2007 Oct.
Artículo
en Francés
| MEDLINE | ID: mdl-18447047
20.
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial.
Front Immunol
; 8: 1551, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29213269